In this interview, Jordi Carreras delves into the fascinating world of Cell Painting, a powerful technology gaining momentum in drug discovery. He shares insights into his groundbreaking research, the unique aspects of Phenaros’ drug discovery platform, and the synergy between academia and industry.
Novartis, Ionis will work together again in the next-generation cardio space
Novartis is once again teaming up with Ionis on a next-generation siRNA cardio drug, picking up another shot in an increasingly competitive space. The deal
August 4, 2023